USD 6.17
↓ -0.25 (-3.89%)
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| BIOX | -3.9 | -2.4 | -15.0 | -39.4 | -46.4 | -45.7 | -61.1 | 7.1 | -35.7 | -35.7 |
| S&P 500 | -1.3 | -2.3 | 0.5 | 5.7 | 10.8 | 30.2 | 24.9 | 88.0 | 187.6 | 33142.5 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | BIOX |
| name | Bioceres Crop Solutions Corp. |
| price | 6.17 |
| changes percentage | -3.89 |
| change | -0.25 |
| day low | 6.15 |
| day high | 6.62 |
| year high | 14.05 |
| year low | 5.71 |
| market cap | 387775245 |
| price avg 50 | 7.58 |
| price avg 200 | 10.68 |
| exchange | NASDAQ |
| volume | 232760 |
| avg volume | 167390 |
| open | 6.42 |
| previous close | 6.42 |
| eps | 0.05 |
| pe | 123.40 |
| earnings announcement | 2024-11-11T05:00:00.000+0000 |
| shares outstanding | 62848500 |
| timestamp | 2024-11-15 21:00:02 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001769484 | |||
| revenue | 464828548 | 419446439 | 10.82 |
| gross profit | 182430752 | 180248507 | 1.21 |
| gross profit ratio | 0.39 | 0.43 | -8.67 |
| research and development expenses | 17183041 | 15345315 | 11.98 |
| operating expenses | 136768276 | 125935785 | 8.60 |
| interest income | 0 | 0 | NaN |
| interest expense | 26871698 | 21229743 | 26.58 |
| ebitda | 54152771 | 61086009 | -11.35 |
| ebitdaratio | 0.12 | 0.17 | -32.45 |
| operating income | 44820596 | 54183965 | -17.28 |
| operating income ratio | 0.1 | 0.13 | -25.36 |
| net income | 3243361 | 18779876 | -82.73 |
| net income ratio | 0.01 | 0.04 | -84.42 |
| eps | 0.05 | 0.3 | -82.80 |
Revenue Growth: revenue increased to 465 million in 2024 from 419 million in 2023 representing a change of 10.82%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 182 million in 2024 from 180 million in 2023 representing a change of 1.21%. This indicates a sales profitability growth, which is a positive sign for the company.
Research and Development (R&D) Expenses: R&D Expenses increased to 17 million in 2024 from 15 million in 2023 representing a change of 11.98%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.
Net Income: Net income increased to 3 million in 2024 from 19 million in 2023 representing a change of -82.73%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Operating Expenses: Operating Expenses increased to 137 million in 2024 from 126 million in 2023 representing a change of 8.6%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 54 million in 2024 from 61 million in 2023 representing a change of -11.35%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 45 million in 2024 from 54 million in 2023 representing a change of -17.28%. The decrease in operating income indicates worse operational performance and decreased profitability.
Earnings per Share (EPS): EPS increased to 0.05 in 2024 from 0.05 in 2023 representing a change of -82.8%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2024Q4 | 2024Q3 | Q/Q change % | |
|---|---|---|---|
| 0001769484 | |||
| revenue | 124313155 | 84000000 | 47.99 |
| gross profit | 46662599 | 42600000 | 9.54 |
| gross profit ratio | 0.38 | 0.51 | -25.98 |
| research and development expenses | 5368622 | 2219389 | 141.90 |
| operating expenses | 36590309 | 30700000 | 19.19 |
| interest income | -1 | 20657 | -100.00 |
| interest expense | 8158495 | 4400000 | 85.42 |
| ebitda | 9077806 | 16216384 | -44.02 |
| ebitdaratio | 0.07 | 0.15 | -50.13 |
| operating income | 9483266 | 11900000 | -20.31 |
| operating income ratio | 0.08 | 0.14 | -46.15 |
| net income | -1530680 | 9500000 | -116.11 |
| net income ratio | -0.01 | 0.11 | -110.89 |
| eps | -0.02 | 0.15 | -116.27 |
Revenue Growth: revenue decreased to 124 million in 2024Q4 from 84 million in 2024Q3 representing a change of 47.99%. This indicates a sales shrinking, which is a negative sign for the company.
Operating Expenses: Operating Expenses increased to 37 million in 2024Q4 from 31 million in 2024Q3 representing a change of 19.19%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Net Income: Net income decreased to -2 million in 2024Q4 from 10 million in 2024Q3 representing a change of -116.11%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to -0.02 in 2024Q4 from -0.02 in 2024Q3 representing a change of -116.27%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
Gross Profit: Gross Profit increased to 47 million in 2024Q4 from 43 million in 2024Q3 representing a change of 9.54%. This indicates a sales profitability growth, which is a positive sign for the company.
Research and Development (R&D) Expenses: R&D Expenses increased to 5 million in 2024Q4 from 2 million in 2024Q3 representing a change of 141.9%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 9 million in 2024Q4 from 16 million in 2024Q3 representing a change of -44.02%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to 9 million in 2024Q4 from 12 million in 2024Q3 representing a change of -20.31%. The increase in operating income indicates better operational performance and increased profitability.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001769484 | |||
| total assets | 850628347 | 818059158 | 3.98 |
| total liabilities | 501063986 | 487563051 | 2.77 |
| total equity | 349308468 | 330496107 | 5.69 |
| cash and cash equivalents | 44473270 | 48129194 | -7.60 |
| short term investments | 11695528 | 11922317 | -1.90 |
| long term investments | 40420906 | 39741719 | 1.71 |
| total current assets | 408668037 | 397114401 | 2.91 |
| total non current assets | 441960310 | 420944757 | 4.99 |
| total current liabilities | 329505846 | 298712534 | 10.31 |
| total non current liabilities | 171558140 | 188850517 | -9.16 |
| common stock | 6500 | 6493 | 0.11 |
| retained earnings | -10659656 | -13903017 | 23.33 |
| total debt | 270945903 | 257412974 | 5.26 |
Total Assets: Total Assets increased to 851 million in 2024 from 818 million in 2023 representing a change of 3.98%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 349 million in 2024 from 330 million in 2023 representing a change of 5.69%. This indicates an increase in shareholders' equity.
Total Current Assets: Total Current Assets increased to 409 million in 2024 from 397 million in 2023 representing a change of 2.91%. This indicates a better liquidity position.
Common Stock: Common Stock increased to 0 in 2024 from 0 in 2023 representing a change of 0.11%. This indicates an increase in ownership interest.
Retained Earnings: Retained Earnings increased to -11 million in 2024 from -14 million in 2023 representing a change of 23.33%. This indicates an accumulated profits.
Total Liabilities: Total Liabilities increased to 501 million in 2024 from 488 million in 2023 representing a change of 2.77%. This indicates an increase in overall liabilities.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 44 million in 2024 from 48 million in 2023 representing a change of -7.6%. This indicates a decrease in available liquid assets.
Short Term Investments: Short Term Investments decreased to 12 million in 2024 from 12 million in 2023 representing a change of -1.9%. This indicates a decrease in short-term investment holdings.
Total Current Liabilities: Total Current Liabilities increased to 330 million in 2024 from 299 million in 2023 representing a change of 10.31%. This indicates a higher short-term debt burden.
Total Debt: Total Debt increased to 271 million in 2024 from 257 million in 2023 representing a change of 5.26%. This indicates an increase in overall debt burden.
| 2024Q4 | 2024Q3 | Q/Q change % | |
|---|---|---|---|
| 0001769484 | |||
| total assets | 850628347 | 837000000 | 1.63 |
| total liabilities | 501063986 | 504100000 | -0.60 |
| total equity | 349308468 | 348600000 | 0.20 |
| cash and cash equivalents | 44473270 | 16399999 | 171.18 |
| short term investments | 11695528 | 16500000 | -29.12 |
| long term investments | 40420906 | 45400000 | -10.97 |
| total current assets | 408668037 | 408100000 | 0.14 |
| total non current assets | 441960310 | 428900000 | 3.05 |
| total current liabilities | 329505846 | 335400000 | -1.76 |
| total non current liabilities | 171558140 | 168700000 | 1.69 |
| common stock | 6500 | 313400000 | -100.00 |
| retained earnings | -10659656 | -9128976 | -16.77 |
| total debt | 270945903 | 270700000 | 0.09 |
Total Assets: Total Assets increased to 851 million in 2024Q4 from 837 million in 2024Q3 representing a change of 1.63%. Suggesting a growth in asset holdings.
Total Liabilities: Total Liabilities decreased to 501 million in 2024Q4 from 504 million in 2024Q3 representing a change of -0.6%. This indicates a decrease in overall liabilities.
Total Equity: Total Equity increased to 349 million in 2024Q4 from 349 million in 2024Q3 representing a change of 0.2%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 44 million in 2024Q4 from 16 million in 2024Q3 representing a change of 171.18%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 409 million in 2024Q4 from 408 million in 2024Q3 representing a change of 0.14%. This indicates a better liquidity position.
Total Current Liabilities: Total Current Liabilities decreased to 330 million in 2024Q4 from 335 million in 2024Q3 representing a change of -1.76%. This indicates a lower short-term debt burden.
Short Term Investments: Short Term Investments decreased to 12 million in 2024Q4 from 16 million in 2024Q3 representing a change of -29.12%. This indicates a decrease in short-term investment holdings.
Common Stock: Common Stock decreased to 0 in 2024Q4 from 313 in 2024Q3 representing a change of -100.0%. This indicates a decrease in ownership interest.
Retained Earnings: Retained Earnings decreased to -11 million in 2024Q4 from -9 million in 2024Q3 representing a change of -16.77%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 271 million in 2024Q4 from 271 million in 2024Q3 representing a change of 0.09%. This indicates an increase in overall debt burden.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001769484 | |||
| net change in cash | -3655924 | 14653928 | -124.95 |
| operating cash flow | 41716586 | 2588792 | 1,511.43 |
| free cash flow | 18934175 | -19974397 | 194.79 |
| capital expenditure | -22782411 | -22563189 | -0.97 |
| depreciation and amortization | 21295312 | 19390601 | 9.82 |
| deferred income tax | 3778615 | -1068652 | 453.59 |
| stock based compensation | 14134885 | 3415108 | 313.89 |
| accounts payables | 14234092 | -4501398 | 416.21 |
| inventory | 14176656 | -11066489 | 228.10 |
| acquisitions net | 37508 | 4373265 | -99.14 |
| investments in property plant and equipment | -9789574 | -22563189 | 56.61 |
| net cash used for investing activites | -28728255 | -25725670 | -11.67 |
| debt repayment | 18324702 | 59217415 | -69.06 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | -734388 | -2996947 | 75.50 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -10055867 | 32954000 | -130.51 |
| cash at end of period | 44473270 | 48129194 | -7.60 |
| accounts receivables | -51648303 | -56867123 | 9.18 |
| cash at beginning of period | 48129194 | 33475266 | 43.78 |
Net Change in Cash: Net Change in Cash decreased to -4 million in 2024 from 15 million in 2023 representing a change of -124.95%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Deferred Income Tax: Deferred Income Tax increased to 4 million in 2024 from -1 million in 2023 representing a change of 453.59%. This indicates that the company's tax liability for future periods has increased.
Stock-Based Compensation: Stock-Based Compensation increased to 14 million in 2024 from 3 million in 2023 representing a change of 313.89%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 14 million in 2024 from 5 million in 2023 representing a change of 416.21%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to -52 in 2024 from -57 million in 2023 representing a change of 9.18%. This suggests that the company is less capable of collecting payments from its customers.
Operating Cash Flow: Operating Cash Flow increased to 42 million in 2024 from 3 million in 2023 representing a change of 1511.43%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 19 million in 2024 from -20 million in 2023 representing a change of 194.79%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -23 million in 2024 from -23 million in 2023 representing a change of -0.97%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
| 2024Q4 | 2024Q3 | Q/Q change % | |
|---|---|---|---|
| 0001769484 | |||
| operating cash flow | 23256785 | -17389985 | 233.74 |
| free cash flow | 17201743 | -19093191 | 190.09 |
| capital expenditure | -6055042 | -1703206 | -255.51 |
| depreciation and amortization | 6610386 | 4942277 | 33.75 |
| deferred income tax | -4027980 | -4127105 | 2.40 |
| stock based compensation | 2653522 | 2954149 | -10.18 |
| accounts receivables | 1747273 | -9996948 | 117.48 |
| accounts payables | -2428487 | 4795159 | -150.64 |
| inventory | 6599104 | -6147656 | 207.34 |
| acquisitions net | 37508 | 122600 | -69.41 |
| investments in property plant and equipment | -2016131 | -1703206 | -18.37 |
| net cash used for investing activites | -295058 | -1370376 | 78.47 |
| debt repayment | 14185388 | 16073071 | -11.74 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 5321315 | 10900052 | -51.18 |
| net change in cash | 28112071 | -8040738 | 449.62 |
| cash at end of period | 44473270 | 16361199 | 171.82 |
| cash at beginning of period | 16361199 | 24401937 | -32.95 |
Net Change in Cash: Net Change in Cash increased to 28 million in 2024Q4 from -8 million in 2024Q3 representing a change of 449.62%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 23 million in 2024Q4 from -17 million in 2024Q3 representing a change of 233.74%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 17 million in 2024Q4 from -19 million in 2024Q3 representing a change of 190.09%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -6 million in 2024Q4 from -2 million in 2024Q3 representing a change of -255.51%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 3 million in 2024Q4 from 3 million in 2024Q3 representing a change of -10.18%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 2 million in 2024Q4 from 5 million in 2024Q3 representing a change of -150.64%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Deferred Income Tax: Deferred Income Tax increased to -4 million in 2024Q4 from -4 million in 2024Q3 representing a change of 2.4%. This indicates that the company's tax liability for future periods has increased.
Accounts Receivables: Accounts Receivables increased to 2 in 2024Q4 from -10 million in 2024Q3 representing a change of 117.48%. This suggests that the company is less capable of collecting payments from its customers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q1 2025 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2024-06-30 | 2023-06-30 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2024 | 2023 | NaN |
| revenue per share | 7.4 | 6.75 | 9.60 |
| net income per share | 0.05 | 0.3 | -82.92 |
| operating cash flow per share | 0.66 | 0.04 | 1,493.63 |
| free cash flow per share | 0.3 | -0.32 | 193.75 |
| cash per share | 0.89 | 0.97 | -7.50 |
| book value per share | 5.56 | 5.32 | 4.60 |
| tangible book value per share | 0.99 | 0.72 | 38.59 |
| shareholders equity per share | 5.0 | 4.81 | 3.91 |
| interest debt per share | 4.56 | 4.26 | 7.03 |
| market cap | 699410635.77 | 830271655.52 | -15.76 |
| enterprise value | 925883268.77 | 1039555435.52 | -10.93 |
| pe ratio | 215.64 | 44.21 | 387.76 |
| price to sales ratio | 1.5 | 1.98 | -23.99 |
| pocfratio | 16.77 | 320.72 | -94.77 |
| pfcf ratio | 36.94 | -41.57 | 188.87 |
| pb ratio | 2.23 | 2.78 | -19.83 |
| ptb ratio | 2.23 | 2.78 | -19.83 |
| ev to sales | 1.99 | 2.48 | -19.63 |
| enterprise value over ebitda | 17.1 | 17.02 | 0.47 |
| ev to operating cash flow | 22.19 | 401.56 | -94.47 |
| ev to free cash flow | 48.9 | -52.04 | 193.96 |
| earnings yield | 0.0 | 0.02 | -79.50 |
| free cash flow yield | 0.03 | -0.02 | 212.53 |
| debt to equity | 0.83 | 0.81 | 1.48 |
| debt to assets | 0.31 | 0.3 | 2.54 |
| net debt to ebitda | 4.18 | 3.43 | 22.07 |
| current ratio | 1.24 | 1.33 | -6.71 |
| interest coverage | 1.67 | 2.55 | -34.65 |
| income quality | 6.67 | 0.13 | 5,096.06 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.17 | 0.17 | -0.48 |
| research and ddevelopement to revenue | 0.04 | 0.04 | 1.04 |
| intangibles to total assets | 0.34 | 0.35 | -3.43 |
| capex to operating cash flow | 0.55 | 8.72 | -93.73 |
| capex to revenue | 0.05 | 0.05 | -8.89 |
| capex to depreciation | 1.07 | 1.16 | -8.06 |
| stock based compensation to revenue | 0.03 | 0.01 | 273.48 |
| graham number | 2.41 | 5.72 | -57.87 |
| roic | 0.05 | 0.11 | -53.82 |
| return on tangible assets | 0.01 | 0.04 | -83.69 |
| graham net net | -3.5 | -3.51 | 0.41 |
| working capital | 79162191 | 98401867 | -19.55 |
| tangible asset value | 62427640 | 44548719 | 40.13 |
| net current asset value | -92395949 | -90448650 | -2.15 |
| invested capital | 452473942 | 466139665 | -2.93 |
| average receivables | 200676400.5 | 156699333.5 | 28.06 |
| average payables | 154128197.5 | 135371983 | 13.86 |
| average inventory | 133398859.5 | 133337626 | 0.05 |
| days sales outstanding | 169.64 | 161.26 | 5.19 |
| days payables outstanding | 209.34 | 223.23 | -6.22 |
| days of inventory on hand | 163.14 | 214.51 | -23.94 |
| receivables turnover | 2.15 | 2.26 | -4.94 |
| payables turnover | 1.74 | 1.64 | 6.64 |
| inventory turnover | 2.24 | 1.7 | 31.48 |
| roe | 0.01 | 0.06 | -83.56 |
| capex per share | 0.36 | 0.36 | -0.14 |
ROE: Return on Equity (ROE) decreased to 0.01 on 2024-06-30 from 0.06 on 2023-06-30, representing a change of -83.56%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 215.64 on 2024-06-30 from 44.21 on 2023-06-30, representing a change of 387.76%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 1.24 on 2024-06-30 from 1.33 on 2023-06-30, representing a change of -6.71%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.83 on 2024-06-30 from 0.81 on 2023-06-30, representing a change of 1.48%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-06-30 Q4 | 2024-03-31 Q3 | Q/Q change % | |
|---|---|---|---|
| BIOX | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 1.98 | 1.34 | 47.99 |
| net income per share | -0.02 | 0.15 | -116.11 |
| operating cash flow per share | 0.37 | -0.28 | 233.73 |
| free cash flow per share | 0.27 | -0.3 | 190.09 |
| cash per share | 0.89 | 0.52 | 70.72 |
| book value per share | 5.57 | 5.3 | 5.00 |
| tangible book value per share | 0.99 | 0.74 | 35.12 |
| shareholders equity per share | 5.0 | 4.99 | 0.19 |
| interest debt per share | 4.26 | 3.94 | 8.33 |
| market cap | 698989387.53 | 792536000 | -11.80 |
| enterprise value | 925462020.53 | 1046836001 | -11.59 |
| pe ratio | -114.16 | 20.86 | -647.38 |
| price to sales ratio | 5.62 | 9.43 | -40.40 |
| pocfratio | 30.06 | -45.57 | 165.95 |
| pfcf ratio | 40.63 | -41.51 | 197.89 |
| pb ratio | 2.23 | 2.53 | -11.97 |
| ptb ratio | 2.23 | 2.53 | -11.97 |
| ev to sales | 7.44 | 12.46 | -40.26 |
| enterprise value over ebitda | 101.95 | 64.55 | 57.93 |
| ev to operating cash flow | 39.79 | -60.2 | 166.10 |
| ev to free cash flow | 53.8 | -54.83 | 198.13 |
| earnings yield | -0.0 | 0.01 | -118.27 |
| free cash flow yield | 0.02 | -0.02 | 202.15 |
| debt to equity | 0.83 | 0.77 | 6.73 |
| debt to assets | 0.31 | 0.29 | 5.23 |
| net debt to ebitda | 24.95 | 15.68 | 59.09 |
| current ratio | 1.24 | 1.22 | 1.93 |
| interest coverage | 1.16 | 2.7 | -57.02 |
| income quality | -11.18 | -1.88 | -495.01 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.15 | 0.35 | -57.66 |
| research and ddevelopement to revenue | 0.04 | 0.03 | 63.45 |
| intangibles to total assets | 0.34 | 0.34 | -1.45 |
| capex to operating cash flow | 0.26 | -0.1 | 365.83 |
| capex to revenue | 0.05 | 0.02 | 140.22 |
| capex to depreciation | 0.92 | 0.34 | 165.80 |
| stock based compensation to revenue | 0.02 | 0.04 | -39.31 |
| graham number | 1.66 | 4.12 | -59.82 |
| roic | 0.01 | 0.02 | -76.64 |
| return on tangible assets | -0.0 | 0.02 | -115.74 |
| graham net net | -3.5 | -3.94 | 11.13 |
| working capital | 79162191 | 72700000 | 8.89 |
| tangible asset value | 62427640 | 46200000 | 35.12 |
| net current asset value | -92395949 | -96000000 | 3.75 |
| invested capital | 452473942 | 446700000 | 1.29 |
| average receivables | 213609290 | 216617007.5 | -1.39 |
| average payables | 161645523.5 | 160816977 | 0.52 |
| average inventory | 128661951 | 127850000 | 0.64 |
| days sales outstanding | 156.4 | 226.27 | -30.88 |
| days payables outstanding | 187.72 | 350.71 | -46.47 |
| days of inventory on hand | 146.3 | 285 | -48.67 |
| receivables turnover | 0.58 | 0.4 | 44.67 |
| payables turnover | 0.48 | 0.26 | 86.83 |
| inventory turnover | 0.62 | 0.32 | 94.81 |
| roe | -0.0 | 0.03 | -116.08 |
| capex per share | 0.1 | 0.03 | 255.50 |
ROE: Return on Equity (ROE) decreased to -0.00 on 2024-06-30 Q4 from 0.03 on 2024-03-31 Q3, representing a change of -116.08%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -114.16 on 2024-06-30 Q4 from 20.86 on 2024-03-31 Q3, representing a change of -647.38%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 1.24 on 2024-06-30 Q4 from 1.22 on 2024-03-31 Q3, representing a change of 1.93%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.83 on 2024-06-30 Q4 from 0.77 on 2024-03-31 Q3, representing a change of 6.73%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2024-11-12 22:19:10
Bioceres' 1Q25 results were challenging due to adverse weather in Argentina, affecting crop nutrition, protection, and seeds, but potential recovery is expected in 2Q25. BIOX has depreciated significantly, now trading at $6.7 per share, with a market cap of $400 million, making it a more interesting Hold. Despite some improvements, HB4 commercialization remains underwhelming, and financial risks persist, warranting caution before investing in potential developments.
Sentiment: Positive
Publish Date: 2024-11-12 12:19:28
Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q1 2025 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Paula Savanti – Head-Investor Relations Federico Trucco – Chief Executive Officer Enrique López Lecube – Chief Financial Officer Conference Call Participants Ben Klieve – Lake Street Capital Markets Kristen Owen – Oppenheimer Kemp Dolliver – Brookline Capital Markets Andrew Steinhardt – Canaccord Genuity Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Bioceres Crop Solutions Fiscal First Quarter 2025 Financial and Operational Results Call.
Sentiment: Positive
Publish Date: 2024-11-11 19:26:00
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons.
Sentiment: Positive
Publish Date: 2024-10-31 08:30:00
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, November 12, 2024 at 8:30 a.m. Eastern Time to discuss its results for the fiscal first quarter ended September 30, 2024. A press release detailing these results will be.
Sentiment: Positive
Publish Date: 2024-09-30 07:30:04
For retail investors, momentum and trends can be drivers of investment decisions and interest. The stocks that analysts and other investors are talking about most may hold a special appeal (although timing the market and ensuring that you buy in at an appropriate time are difficult challenges).
Sentiment: Negative
Publish Date: 2024-09-26 08:37:43
The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
Sentiment: Negative
Publish Date: 2024-09-17 04:35:31
Bioceres' 4Q24 results disappointed, with flat profitability and a 15% stock drop, driven by a bear market in agricultural commodities and commercialization challenges for HB4 products. The company's debt rose, particularly short term, with unclear maturity risks, and profitability challenges persisted despite top-line growth. Bioceres is shifting tactics for HB4, reducing the priority of its identity-protected program to manage working capital and focusing more on its bio solutions segment.
Sentiment: Positive
Publish Date: 2024-09-13 02:00:00
ENDEAVOUR ACHIEVES COMMERCIAL PRODUCTION AT BIOX EXPANSION AND LAFIGUÉ GROWTH PROJECTS HIGHLIGHTS: • Commercial production achieved on budget and on schedule at the Sabodala-Massawa BIOX Expansion and the Lafigué mine on 1 August 2024 • Organic growth phase completed improving the quality of the portfolio and underpinning the transition to a phase focused on free cash flow generation • BIOX Expansion achieved commercial production; operating with 94% plant availability at 80% of nameplate capacity, with average recoveries of above 72% during July and August • Lafigué mine achieved commercial production only one month after the first gold pour; operating with 87% plant availability at 72% of nameplate capacity, with average recoveries of above 95% during August • The Group remains on track to achieve its full-year production guidance with AISC near the top end of the guided range London , 13 September 2024 – Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) (“Endeavour”, the “Group” or the “Company”) is pleased to announce that it has achieved commercial production at both its Sabodala-Massawa BIOX Expansion in Senegal and at its Lafigué mine in Côte d'Ivoire, effective as of 1 August 2024. Both projects have been completed on budget and on schedule, with the full ramp up to nameplate capacity underway.
Sentiment: Positive
Publish Date: 2024-09-13 02:00:00
ENDEAVOUR ACHIEVES COMMERCIAL PRODUCTION AT BIOX EXPANSION AND LAFIGUÉ GROWTH PROJECTS HIGHLIGHTS: • Commercial production achieved on budget and on schedule at the Sabodala-Massawa BIOX Expansion and the Lafigué mine on 1 August 2024 • Organic growth phase completed improving the quality of the portfolio and underpinning the transition to a phase focused on free cash flow generation • BIOX Expansion achieved commercial production; operating with 94% plant availability at 80% of nameplate capacity, with average recoveries of above 72% during July and August • Lafigué mine achieved commercial production only one month after the first gold pour; operating with 87% plant availability at 72% of nameplate capacity, with average recoveries of above 95% during August • The Group remains on track to achieve its full-year production guidance with AISC near the top end of the guided range London , 13 September 2024 – Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) (“Endeavour”, the “Group” or the “Company”) is pleased to announce that it has achieved commercial production at both its Sabodala-Massawa BIOX Expansion in Senegal and at its Lafigué mine in Côte d'Ivoire, effective as of 1 August 2024. Both projects have been completed on budget and on schedule, with the full ramp up to nameplate capacity underway.
Sentiment: Positive
Publish Date: 2024-09-10 13:02:07
Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q4 2024 Earnings Conference Call September 10, 2024 8:30 AM ET Company Participants Paula Savanti - Head of IR Federico Trucco - CEO Enrique Lopez Lecube - CFO Conference Call Participants Ben Klieve - Lake Street Capital Markets Kristen Owen - Oppenheimer Kemp Dolliver - Brookline Capital Markets Austin Moeller - Canaccord Scott Fortune - ROTH Capital Partners Operator Good morning. Welcome to today's Bioceres Crop Solutions, Fiscal Fourth Quarter and Full Year 2024 Financial Results Conference call.
Sentiment: Positive
Publish Date: 2024-09-09 19:24:00
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter and fiscal year ended June 30, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All.
Sentiment: Positive
Publish Date: 2024-08-28 09:00:00
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced today that the United States Department of Agriculture (USDA) has favorably concluded its Regulatory Status Review (RSR) for HB4 wheat technology. The announcement can be found here: https://www.aphis.usda.gov/biotech-regulatory-status/regulatory-status-review-table. The USDA, through the Animal and Plant Health Inspection Service (APHIS), reviewed HB4 wheat and concluded that it does not pose an increas.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
